NBIX
Neurocrine Biosciences, Inc. · Healthcare
Director Stephen A Sherwin sold $4.1M of Neurocrine Biosciences, Inc.
Sold$4,132,969
$165.32Price
25,000Shares
−61%Stake
What NBIX did after the filing
- The stock from Wed, Jun 10 open, $167.80
- +4.7%
- S&P 500, same days
- +0.8%
Measured over 30 trading days, to the Jul 24 close.
Traded Fri, Jun 5. Filed Tue, Jun 9, 5:40 PM ET, after the close. Returns use the Jun 10 open and the Jul 24 close. Not investment advice.